• Je něco špatně v tomto záznamu ?

Single-cell profiling of surface glycosphingolipids opens a new dimension for deconvolution of breast cancer intratumoral heterogeneity and phenotypic plasticity

J. Procházková, R. Fedr, B. Hradilová, B. Kvokačková, J. Slavík, O. Kováč, M. Machala, P. Fabian, J. Navrátil, S. Kráčalíková, M. Levková, P. Ovesná, J. Bouchal, K. Souček

. 2024 ; 65 (9) : 100609. [pub] 20240730

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019077

Glycosylated sphingolipids (GSLs) are a diverse group of cellular lipids typically reported as being rare in normal mammary tissue. In breast cancer (BCa), GSLs have emerged as noteworthy markers associated with breast cancer stem cells, mediators of phenotypic plasticity, and contributors to cancer cell chemoresistance. GSLs are potential surface markers that can uniquely characterize the heterogeneity of the tumor microenvironment, including cancer cell subpopulations and epithelial-mesenchymal plasticity (EMP). In this study, mass spectrometry analyses of the total sphingolipidome in breast epithelial cells and their mesenchymal counterparts revealed increased levels of Gb3 in epithelial cells and significantly elevated GD2 levels in the mesenchymal phenotype. To elucidate if GSL-related epitopes on BCa cell surfaces reflect EMP and cancer status, we developed and rigorously validated a 12-color spectral flow cytometry panel. This panel enables the simultaneous detection of native GSL epitopes (Gb3, SSEA1, SSEA3, SSEA4, and GD2), epithelial-mesenchymal transition markers (EpCAM, TROP2, and CD9), and lineage markers (CD45, CD31, and CD90) at the single-cell level. Next, the established panel was used for the analysis of BCa primary tumors and revealed surface heterogeneity in SSEA1, SSEA3, SSEA4, GD2, and Gb3, indicative of native epitope presence also on non-tumor cells. These findings further highlighted the phenotype-dependent alterations in GSL surface profiles, with differences between epithelial and stromal cells in the tumor. This study provides novel insights into BCa heterogeneity, shedding light on the potential of native GSL-related epitopes as markers for EMP and cancer status in fresh clinical samples. The developed single-cell approach offers promising avenues for further exploration.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019077
003      
CZ-PrNML
005      
20241024111630.0
007      
ta
008      
241015s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jlr.2024.100609 $2 doi
035    __
$a (PubMed)39084491
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Procházková, Jiřina $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic. Electronic address: prochazkova@ibp.cz
245    10
$a Single-cell profiling of surface glycosphingolipids opens a new dimension for deconvolution of breast cancer intratumoral heterogeneity and phenotypic plasticity / $c J. Procházková, R. Fedr, B. Hradilová, B. Kvokačková, J. Slavík, O. Kováč, M. Machala, P. Fabian, J. Navrátil, S. Kráčalíková, M. Levková, P. Ovesná, J. Bouchal, K. Souček
520    9_
$a Glycosylated sphingolipids (GSLs) are a diverse group of cellular lipids typically reported as being rare in normal mammary tissue. In breast cancer (BCa), GSLs have emerged as noteworthy markers associated with breast cancer stem cells, mediators of phenotypic plasticity, and contributors to cancer cell chemoresistance. GSLs are potential surface markers that can uniquely characterize the heterogeneity of the tumor microenvironment, including cancer cell subpopulations and epithelial-mesenchymal plasticity (EMP). In this study, mass spectrometry analyses of the total sphingolipidome in breast epithelial cells and their mesenchymal counterparts revealed increased levels of Gb3 in epithelial cells and significantly elevated GD2 levels in the mesenchymal phenotype. To elucidate if GSL-related epitopes on BCa cell surfaces reflect EMP and cancer status, we developed and rigorously validated a 12-color spectral flow cytometry panel. This panel enables the simultaneous detection of native GSL epitopes (Gb3, SSEA1, SSEA3, SSEA4, and GD2), epithelial-mesenchymal transition markers (EpCAM, TROP2, and CD9), and lineage markers (CD45, CD31, and CD90) at the single-cell level. Next, the established panel was used for the analysis of BCa primary tumors and revealed surface heterogeneity in SSEA1, SSEA3, SSEA4, GD2, and Gb3, indicative of native epitope presence also on non-tumor cells. These findings further highlighted the phenotype-dependent alterations in GSL surface profiles, with differences between epithelial and stromal cells in the tumor. This study provides novel insights into BCa heterogeneity, shedding light on the potential of native GSL-related epitopes as markers for EMP and cancer status in fresh clinical samples. The developed single-cell approach offers promising avenues for further exploration.
650    _2
$a lidé $7 D006801
650    12
$a nádory prsu $x metabolismus $x patologie $7 D001943
650    12
$a glykosfingolipidy $x metabolismus $x analýza $7 D006028
650    _2
$a ženské pohlaví $7 D005260
650    12
$a analýza jednotlivých buněk $x metody $7 D059010
650    12
$a epitelo-mezenchymální tranzice $7 D058750
650    _2
$a fenotyp $7 D010641
655    _2
$a časopisecké články $7 D016428
700    1_
$a Fedr, Radek $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
700    1_
$a Hradilová, Barbora $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Kvokačková, Barbora $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Slavík, Josef $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Brno, Czech Republic
700    1_
$a Kováč, Ondrej $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Brno, Czech Republic
700    1_
$a Machala, Miroslav $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Brno, Czech Republic
700    1_
$a Fabian, Pavel $u Breast Cancer Centre, Masaryk Memorial Cancer Institute, Brno, Czech Republic; Prostate Cancer Centre, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Navrátil, Jiří $u Prostate Cancer Centre, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Kráčalíková, Simona $u Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic
700    1_
$a Levková, Monika $u Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic
700    1_
$a Ovesná, Petra $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Bouchal, Jan $u Department of Clinical and Molecular Pathology, Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic; Department of Clinical and Molecular Pathology, University Hospital, Olomouc, Czech Republic
700    1_
$a Souček, Karel $u Department of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic. Electronic address: ksoucek@ibp.cz
773    0_
$w MED00002766 $t Journal of lipid research $x 1539-7262 $g Roč. 65, č. 9 (2024), s. 100609
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39084491 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111623 $b ABA008
999    __
$a ok $b bmc $g 2201725 $s 1231050
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 65 $c 9 $d 100609 $e 20240730 $i 1539-7262 $m Journal of lipid research $n J Lipid Res $x MED00002766
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Možnosti archivace